Related Experiment Videos
[Digitalization of the arrhythmic heart patient]
Insights
Digitalis remains a cornerstone in treating heart arrhythmia, including atrial fibrillation and ventricular extrasystole. Modern therapies enhance its use, but the arrhythmogenic potential of digitalis requires careful consideration.
Area of Science:
- Cardiology
- Pharmacology
Context:
- Digitalis therapy has a long history in treating cardiac conditions.
- Arrhythmia is a common and significant clinical manifestation in heart patients.
Purpose:
- To examine the role of Digitalis in managing various arrhythmias.
- To discuss the integration of Digitalis with modern therapeutic approaches.
Summary:
- Focuses on paroxysmal tachycardia, flutter, and atrial fibrillation.
- Addresses ventricular extrasystole, sinoatrial node disease, and Wolff-Parkinson-White syndrome.
- Highlights improved long-term management of chronic arrhythmic patients through combination therapies.
Impact:
- Combination therapies with new antiarrhythmic drugs, diuretics, electrolytes, and electrical stimulation improve Digitalis utilization.
- Acknowledges the inherent arrhythmogenic potential of Digitalis, necessitating careful monitoring.
Abstract:
Digitalis combines a longstanding tradition with constant up-to-dateness. Kinetic maintenance therapy is very often required for heart patients with arrhythmia as one of their most striking clinical manifestations. The well-known questions of paroxystic tachycardia, flutter and atrial fibrillation are examined, and attention is concentrated on ventricular extrasystole, sinoatrial node disease, and Wolff-Parkinson-White syndrome. It is clear that combinations with recently introduced antiarrhythmic drugs, and administration of diuretics and electrolytes, and the employment of electrical stimulation have facilitated the long-term treatment of the chronic arrhythmic heart patient and brought about the better utilisation of digitalic substances. Their arrhythmogenic potential, however, cannot be overlooked.